Table 1.

Selected recombinant hepatitis B vaccine internationally or locally applied.

Vaccine name	Company, Country	HBsAg (µg)/volume (mL)	Other vaccine	Applicable subject
Engerix-B	GlaxoSmithKline, USA	10/0.5	None	From birth to age 19 y
		20/1.0	None	Adults (≥20 y)
		40/2.0	None	Immunocompromised individuals
Recombivax HB	Merck & Co, USA	5/0.5	None	From birth to age 19 y
		10/1.0	None	Adults (≥20 y)
		40/1.0	None	Immunocompromised individuals
Hepavax-Gene	Berna, Korea	10/0.5	None	Infants and children
		20/1.0	None	Adults
Euvax-B	Lucky Goldstar Chemical, Korea	10/0.5	None	Infants and children
		20/1.0	None	Adults
Revac-B	Bharat Biotech, India	10/0.5	None	≤10 y old children
		20/1.0	None	>10 y old children and adults
Heberbiovac-HB	Heber Biotec, Cuba	10/0.5	None	≤10 y old children
		10/1.0	None	>10 y old children and adults
HBvaxPro	MSD Pharma, Singapore	5/0.5	None	Pediatric/adolescent
		10/1.0	None	Adults
		40/1.0	None	Predialysis/dialysis patients
Hanxin	Hiss Bio, China	10/0.5	None	All ages
		20/1.0	None	All ages
Tiantan	Tiantan, China	10/0.5	None	<16 y
		20/1.0	None	≥16 y
Kangtai	Kangtai, China	10/0.5	None	<16 y
		20/1.0	None	≥16 y
Twinrix	GlaxoSmithKline, USA	20/1.0	Hepatitis A	1–15 y old
		20/1.0	Hepatitis A	Adult and adolescent ≥16 y
Pediarix	GlaxoSmithKline, USA	10/0.5	DTP/IPV	6 weeks to 6 y old
EasySix	Panacea Biotec, India	10/0.5	DTP-Hib/IPV	6 weeks to 6 y old
Pentavac SD-R	Human Biologicals, India	10/0.5	DTPa-/Hib	6 weeks to 6 y old
Quinvaxem	Crucell, Netherlands	10/0.5	DTPa-/Hib	age 6 weeks to 24 months
Hexaxim	Sanofi Pasteur, France	10/0.5	DTPa-IPV/Hib	age 6 weeks to 24 months

DTPa-/Hib: diphtheria, tetanus, pertussis, and Haemophilus influenzae type b

IPV: inactivated polio vaccine.